Bliss Gvs Pharma Q2 Results

  • BSE: 506197
  • NSE: BLISSGVS
  • ISIN: INE416D01022
  • Sector: Biotechnology & Drugs
BSE
132.250.75 (0.57%)
Volume36.39 K
Updated: Mon 25 Nov, 2024 | 15:28:00
NSE
132.420.87 (0.66%)
Volume8.33 L
Updated: Mon 25 Nov, 2024 | 15:44:17
Today: 132.10
138.20
52-Wk: 92.25
148.95

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

  • Total Income
    ₹217.68 Cr.
    (18.53%)
  • Operating Profit
    ₹34.50 Cr.
    (25.52%)
  • Profit After Tax
    ₹24.26 Cr.
    (17.21%)
  • Operating Margin
    15.85%
    (-30.02%)
Note: Comparison is on YoY basis

Quarterly - Bliss Gvs Pharma Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 217.68159.52-%211.88-%
Selling/ General/ Admin Expenses Total 27.5123.52-%23.26-%
Depreciation/ Amortization 6.986.19-%6.39-%
Other Operating Expenses Total 33.7727.36-%34.51-%
Total Operating Expense 183.18141.50-%163.90-%
Operating Income 34.5018.02-%47.98-%
Net Income Before Taxes 35.7121.65-%59.13-%
Net Income 24.2614.69-%42.31-%
Diluted Normalized EPS 2.291.38-%3.98-%

EQUITY QUICK LINKS

FROM MARKETS

RELATED LINKS

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market

      HomeMarketsPremiumInstant LoanMint Shorts

      Wait for it…

      Log in to our website to save your bookmarks. It'll just take a moment.